AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

NCT05826015 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Trial did not go forward

Conditions

Recurrent High Grade Uterine Cancer

Interventions

DRUG: Paclitaxel
DRUG: Batiraxcept

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]